跳至主要内容
临床试验/NCT06651216
NCT06651216尚未招募不适用

Impact of Breast Milk miRNAs on the Infant Gut Microbiota

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
Explore the effect of breast milk on the composition of fecal miRNAs in infants

研究概览

简要总结

The first 1000 days of life are a critical period for future health. A healthy gut microbiota (GM) is essential for preventing both short-term and long-term health issues. Breast milk (BM) plays a key role in establishing the GM, as, unlike formula milk, it contains miRNAs that may interact with and modulate the microbiota.

Primary Objective: To study the effect of BM on the composition of fecal miRNAs in exclusively breastfed infants compared to those fed with formula milk at different times (D10, D30, D60, M6, M12).

Secondary Objectives:

Analyze the effect of BM miRNAs on infant fecal microbiota, taking environmental confounding factors into account.

Study the influence of BM microbiota on miRNA profiles in the milk. Examine the effect of BM microbiota on the infants' gut microbiota. Explore the links between BM miRNAs, infant gut microbiota, and intestinal inflammation.

详细描述

The first 1,000 days of life are a critical period that significantly contributes to the programming of an individual's health. It is increasingly evident that establishing a healthy gut microbiota (GM) plays an important role in preventing both short- and long-term health issues.

Among the factors influencing the establishment of the infant's gut microbiota, breast milk (BM) plays a fundamental role. Unlike formula milk, breast milk contains miRNAs that are potential mediators of the interactions between the host and the microbiota. Thus, we hypothesize that miRNAs from breast milk may be present in the infant's luminal content and interact with their microbiota, thereby modulating it.

Main Objective: Explore the effect of breast milk on the composition of fecal miRNAs in infants.

Primary Evaluation Criterion: Profiles and quantities of miRNAs at different time points (D10, D30, D60, M6, and M12) in the stools of exclusively breastfed infants compared to those fed with formula milk.

Secondary Objectives:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women in the 3rd trimester of pregnancy (3T) with a normal course of pregnancy up to 39 weeks consulting for the monitoring visit at the Robert-Debré hospital.
  • Patients who did not receive antibiotic treatment or probiotics in 3T.
  • Patient with a negative PV for Strepto B
  • Patients who do not have complications such as pre-eclampsia or gestational diabetes.
  • Breastfeeding (+/- milk pump) or exclusive artificial breastfeeding.
  • No opposition from the mother
  • Ability to master the French language required.
  • Freezer at home.
  • Affiliation to a social security scheme.

排除标准

  • Cesarean delivery
  • Perinatal pathologies (Anoxia, IUGR, etc.)
  • Neonatal pathologies (FGR, malformations, etc.)
  • Initial choice of mixed breastfeeding
  • Patient under AME (State Medical Aid)Critères d'exclusions :
  • Antibiotics for the mother or child before day 60
  • Antifungal for the mother or child before day 60
  • Complete cessation of breastfeeding before day 60

结局指标

主要结局

Explore the effect of breast milk on the composition of fecal miRNAs in infants

时间窗: 12 months

profiles and quantities of miRNAs at different times (D10, D30, D60, M6, and M12) in the stools of exclusively breastfed infants compared to those fed with formula milk

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验